Related references
Note: Only part of the references are listed.Ag-specific CD4 T cells promote innate immune responses in liver ischemia reperfusion injury
Jianhua Rao et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2019)
Ebi3 promotes T- and B-cell division and differentiation via STAT3
Ning Ma et al.
MOLECULAR IMMUNOLOGY (2019)
Mesenchymal stromal cells-derived exosomes alleviate ischemia/reperfusion injury in mouse lung by transporting anti-apoptotic miR-21-5p
Ji wei Li et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
BMSCs protect against renal ischemia-reperfusion injury by secreting exosomes loaded with miR-199a-5p that target BIP to inhibit endoplasmic reticulum stress at the very early reperfusion stages
Chenyang Wang et al.
FASEB JOURNAL (2019)
Exosomes Derived from Dendritic Cells Attenuate Liver Injury by Modulating the Balance of Treg and Th17 Cells After Ischemia Reperfusion
Lei Zheng et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Lipid, Protein, and MicroRNA Composition Within Mesenchymal Stem Cell-Derived Exosomes
Hao Deng et al.
CELLULAR REPROGRAMMING (2018)
The microRNA regulatory landscape of MSC-derived exosomes: a systems view
Scott W. Ferguson et al.
SCIENTIFIC REPORTS (2018)
A pooled analysis of mesenchymal stem cell-based therapy for liver disease
Lu Zhao et al.
STEM CELL RESEARCH & THERAPY (2018)
Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer
Pinar Kanlikilicer et al.
EBIOMEDICINE (2018)
hucMSC Exosome-Derived GPX1 Is Required for the Recovery of Hepatic Oxidant Injury
Yongmin Yan et al.
MOLECULAR THERAPY (2017)
Exosomal MicroRNA MiR-1246 Promotes Cell Proliferation, Invasion and Drug Resistance by Targeting CCNG2 in Breast Cancer
Xiu Juan Li et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Exosomes Derived from Mesenchymal Stem Cells Rescue Myocardial Ischaemia/Reperfusion Injury by Inducing Cardiomyocyte Autophagy Via AMPK and Akt Pathways
Liang Liu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Exosomes from Human-Induced Pluripotent Stem Cell-Derived Mesenchymal Stromal Cells (hiPSC-MSCs) Protect Liver against Hepatic Ischemia/Reperfusion Injury via Activating Sphingosine Kinase and Sphingosine-1-Phosphate Signaling Pathway
Yingdong Du et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Hepatoprotective effect of exosomes from human-induced pluripotent stem cell-derived mesenchymal stromal cells against hepatic ischemia-reperfusion injury in rats
Kate Nong et al.
CYTOTHERAPY (2016)
TNFR-Associated Factors 2 and 5 Differentially Regulate the Instructive IL-6 Receptor Signaling Required for Th17 Development
Hiroyuki Nagashima et al.
JOURNAL OF IMMUNOLOGY (2016)
Hepatic ischemia reperfusion injury: A systematic review of literature and the role of current drugs and biomarkers
Marco Cannistra et al.
INTERNATIONAL JOURNAL OF SURGERY (2016)
Modulating CD4+T Cell Migration in the Postischemic Liver: Hepatic Stellate Cells as New Therapeutic Target?
Joerg Reifart et al.
TRANSPLANTATION (2015)
FGF4 and HGF promote differentiation of mouse bone marrow mesenchymal stem cells into hepatocytes via the MAPK pathway
T. Lu et al.
GENETICS AND MOLECULAR RESEARCH (2014)
RORγt-specific transcriptional interactomic inhibition suppresses autoimmunity associated with TH17 cells
Tae-Yoon Park et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Triptolide protects mice from ischemia/reperfusion injury by inhibition of IL-17 production
Chuanxing Wu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
IL-6-gp130-STAT3 in T cells directs the development of IL-17+Th with a minimum effect on that of Treg in the steady state
Mika Nishihara et al.
INTERNATIONAL IMMUNOLOGY (2007)
Share Paper
